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Abstract: The methanol extract of Actaea acuminata roots have been 
previously reported to exhibit significant antianxiety, anticonvulsant and 
antidepressant activities. In present study fractionation of crude bioactive 
methanol extract was carried out using different solvents employing standard 
procedure. Various fractions were evaluated for antianxiety, anticonvulsant 
and antidepressant activities using elevated plus maze model (EPM), maximal 
electroshock-induced convulsions model (MES) and forced / despair swim test 
(FST) respectively. Successive partitioning of bioactive methanol extract was 
done with ethyl acetate and 1-butanol. The ethyl acetate fraction (EAF; 100 
mg/kg), 1-butanol fraction (BF; 25 mg/kg) and remaining methanol extract 
(RME; 70 mg/kg) were subjected to neuropharmacological activities. The 
EAF significantly enhanced entries and average time spent in open arms; 
significantly decreased duration of MES-induced tonic extension phase and 
significantly decreased duration of immobility time of rats in comparison 
to control. BF and RME did not exhibit any neuropharmacological activity. 
Qualitative chemical tests confirmed presence of alkaloids and polyphenols 
in EAF. It is finally concluded that alkaloids and/or polyphenols are bioactive 
constituents of A. acuminata which are responsible for neuropharmacological 
activities.
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1. INTRODUCTION
It has been estimated that mental disorders have increased enormously 
and accounted for about 14% of global burden of disease, and predicted to 




mental illness is more prevalent among US adults and estimated to be 4.5% 
(NIH, 2008). As per data of 2010/11, more than 1.25 million adults utilized 
NHS services for critical mental health problems. It has been reported that 
a professional has treated more than 25% of college students suffering from 
mental health condition in a year (NAMI, 2013). The annual cost of mental 
illness has been estimated to be US$79 billion in the US, and approximately 
US$63 billion results from the loss of productivity (Rockville, 1999). 
A large number of synthetic drugs are available in market to manage 
neuropsychiatric disorders but having drawback of severe side effects. 
Therefore, natural resources seem viable alternative to search for safer and 
effective drugs. A thorough survey of literature reveals that large numbers of 
plants are used in the treatment of CNS disorders. Systematic and scientifically 
structured research is required on most of these plants. Among such plants, 
Actaea acuminata (Wall. ex Royle) H. Hara, commonly known as Himalayan 
Baneberry (family - Ranunculaceae) was shortlisted for present investigation.
A. acuminata has been recorded in traditional texts in the treatment of 
nervous disorders, scrofula, rheumatic fever, inflammation, rheumatism, 
cough and constipation (Anonymous, 1948; Chopra et al., 1956; Kirtikar & 
Basu, 1975; Khare, 2007). 
The methanol extract of the plant has been investigated scientifically for 
neuropharmacological activities (Biswas et al., 2017). The methanol extract 
exhibits significant antianxiety, anticonvulsant and antidepressant activities. 
In continuation to above finding, it was envisaged to fractionate bioactive 
methanol extract and to evaluate antianxiety, anticonvulsant and antidepressant 
activities of various fractions using well established models.  
2. MATERIALS AND METHODS
2.1 Collection and Identification Number of Plant Material
K. R. Indo German American Trading Company, Kurukshetra (Haryana), India 
supplied A. acuminata roots in August, 2015. The identification of the plant 
was confirmed through Dr. Avneet Pal Singh, Assistant Professor, Department 
of Botany, Punjabi University, Patiala, India (Reference No. SPL-110/Bot, 
dated 15-09-2015).
2.2 Solvents
Ethyl acetate, methanol and 1-butanol (E Merck, New Delhi, India) of LR 
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2.3 Fractionation of Methanol Extract (ME)
The methanol extract was prepared using standard procedure (Biswas et al., 
2017). The suspension of ME (100 g) of plant material was prepared in water 
(500 ml). It was then taken in a round bottom flask. The extract was then 
subjected to successive partitioning with ethyl acetate (10 × 250 ml) and 
1-butanol (10 × 250 ml). The separated layers of each solvent were collected 
and pooled. All fractions were concentrated under reduced pressure to get 
ethyl acetate fraction (EAF), 1-butanol fraction (BF) and remaining methanol 
extract (RME). The various fractions were subjected to phytochemical screeing 
for presence of different groups of phytoconstituents (Farnsworth, 1966). 
2.4 Animal Experimentation
S D rats of body weight 200-300 g, either sex, purchased from the Institute of 
Microbial Technology, Chandigarh, India were used for present investigations. 
Normal laboratory pellet diet and water ad libitum were provided to animals. 
The approval of animal studies from Institutional Animal Ethics Committee 
of Punjabi University, Patiala was obtained (Registration number – 107/1999/
CPCSEA, dated 28/04/1999; Approval number – 107/GO/ReBi/S/99/
CPCSEA/2017-04, dated 27-02-2017).   
2.5 Neuropharmacological Activities
Antianxiety, anticonvulsant and antidepressant activities of various fractions 
were evaluated using elevated plus maze model (EPM; Designed from local 
market Patiala as per standard specification), maximal electroshock-induced 
convulsions model (MES; Gupta Scientific Store, Ambala) and forced swim 
test (FST; Gupta Scientific Store, Ambala) respectively (Biswas et al., 2017). 
Diazepam (Triko Pharmaceuticals, Haryana, India; 2 mg/kg, p.o.), phenytoin 
(Epsolin injections®, Zydus Neurosciences, Ahmedabad; 100 mg/kg, i.p.) and 
imipramine Diazepam (Triko Pharmaceuticals, Haryana, India; 5 mg/kg, p.o.) 
were used as standard antianxiety, anticonvulsant and antidepressant drugs 
respectively. The 2% mixture of Tween 80 and distilled water was used as 
vehicle for the preparation of test doses of various fractions.
2.6 Experimental Protocol
Experimental protocol comprising 5 groups of rats (for each activity studies) 
was designed to assess antianxiety, anticonvulsant and antidepressant activities 
of various fractions of ME of A. acuminata roots. The animals of control group 




received respective standard drug. EAF (100 mg/kg, p.o.), BF (25 mg/kg, p.o.) 
and RME (70 mg/kg, p.o.) were served as test groups.
2.7 Statistics
The observations of results were compiled in to data, which were presented 
as mean ± standard deviation (SD). One way analysis of variance (ANOVA) 
followed by Student Newman Keul’s test was applied to compare control, 
standard and test groups (Scheffer, 1980).
3. RESULT
The percentage yields of EAF, BF and RME were 52.63, 11.13 and 35.26%, 
respectively, in relation to ME. Qualitative chemical tests for identification 
of various phytoconstituents confirmed the presence of alkaloids, phenolic 
compounds, steroids and flavonoids in EAF; tannins in BF and carbohydrates, 
proteins in RME. Various fractions were subjected to antianxiety, anticonvulsant 
and antidepressant activities in rats using well established models. The test 
doses were selected on the basis of percentage yields of fractions with respect 
to bioactive ME.
The antianxiety activity was screened after administration of EAF (100 
mg/kg, p.o.), BF (25 mg/kg, p.o.), RME (70 mg/kg, p.o.), diazepam (2 mg/
kg, p.o.) and the control (vehicle, p.o.) of A. acuminata roots in rats using 
EPM model. The results of antianxiety activity such as number of entries and 
average time spent in open arms have been presented in Table 1. Amongst 
various fractions tested, only EAF produced significant antianxiety effect as 
it caused significant increase in open arm entries and time spent by rats in 
comparison to control. Antianxiety activity observed in EAF was statistically 
Table 1: Antianxiety activity of various fractions of ME of A. acuminata roots 
using EPM model.
Treatment Dose (mg/kg) Number of entries in 
open arms
Time spent in open arms 
(sec)
Control Vehicle 3.67 ± 0.51a 5.67 ± 0.51a
Diazepam 2 9.17 ± 0.75* 18.00 ± 0.63*
EAF 100 9.00 ± 0.89* 17.83 ± 0.75*
BF 25 4.67 ± 0.52a 6.50 ± 0.54a
RME 70 3.50 ± 0.54a 5.33 ± 0.51a
n = 6; The data is expressed as Mean ± S.D.; *P<0.05 vs Control; aP<0.05 vs Diazepam; one 
way ANOVA followed by Student-Newman-Keul’s test.
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not different to the standard drug. BF and RME did not exhibit antianxiety 
activity at the tested doses. These observations inferred that only EAF contains 
major constituents which are responsible for CNS activities of the plant.   
The EAF (100 mg/kg, p.o.), BF (25 mg/kg, p.o.), RME (70 mg/kg, p.o.), 
phenytoin (100 mg/kg, i.p.) and the control (vehicle, p.o.) of A. acuminata 
roots were subjected to anticonvulsant activity in rats using MES test. The 
results of anticonvulsant activity parameters such as time spent in extensor 
phase in the rats and percentage protection of animals have been presented 
in Table 2. Amongst various fractions tested, only EAF caused a significant 
decrease in duration of MES-induced tonic extension phase in the rats, thus, 
exhibited anticonvulsant activity. BF and RME did not exhibit anticonvulsant 
activity.
Table 2: Anticonvulsant activity of various fractions of ME of A. acuminata 
roots using MES test.
Treatment Dose (mg/kg) Time spent in extensor 
phase (sec)
% Protection of 
animals
Control Vehicle 11.50 ± 1.04a 33.3
Phenytoin 100 1.33 ± 0.51* 100.0
EAF 100 1.50 ± 0.83* 100.0
BF 25 9.50 ± 1.15a 33.3
RME 70 11.83 ± 0.75a 33.3
n = 6; The data is expressed as Mean ± S.D.; *P<0.05 vs Control; aP<0.05 vs Phenytoin; one 
way ANOVA followed by Student-Newman-Keul’s test.
The EAF (100 mg/kg, p.o.), BF (25 mg/kg, p.o.), RME (70 mg/kg, p.o.), 
imipramine (5 mg/kg, p.o.) and the control (vehicle, p.o.) of A. acuminata 
roots were subjected to antidepressant activity in rats using FST. The results 
of antidepressant activity such as mean immobility time of the rats have been 
presented in Table 3. Amongst various fractions tested, only EAF caused a 
significant decrease in duration of immobility time of the rats in comparison 
to control and statistically not different to the standard drug. BF and RME did 
not exhibit anticonvulsant activity.
4. DISCUSSION
The evaluation of antianxiety activity of A. acuminata roots fractions was done 
using EPM. In this model when animals are exposed to an elevated and open 




in time spent and number of entries in open arms observed infers anxiety in the 
animals (Belzung & Griebel, 2001).
Various fractions of A. acuminata roots were screened for anticonvulsant 
activity using widely employed model, i.e., MES. The model is based on 
the observation of duration of the seizures which was induced by maximal 
electroshock in mice with the help of electroconvulsiometer by passing current 
using ear clip electrodes. The anticonvulsant activity of test drugs in animals 
was assessed based on following parameter (a) time spent by animals in extensor 
phase and (b) percentage protection against MES induced convulsive death in 
mice. The anticonvulsant activity in the animals is confirmed by decrease in the 
duration of extensor phase and maximum percentage of the protection against 
MES induced convulsive deaths in mice (Swinyard et al., 1952).
Forced swimming test was employed to screen various fractions of 
A. acuminata roots for antidepressant activity. In this model, characteristic 
behaviour of immobility is observed in mice when they are forced to swim 
in inescapable specified area. Depression in mice of control group is inferred 
from higher mean time spent in the immobile state (Weiss et al., 1981).
CONCLUSION
The previously reported bioactive methanol extract was fractionated in order 
to get semi-purified fractions. The fractions were screened for antianxiety, 
antidepressant and anticonvulsant activities employing widely used models. 
Amongst various fractions tested, only EAF exhibited significant antianxiety, 
anticonvulsant and antidepressant activities. Phytochemical screening showed 
presence of phenolic compounds, flavonoids and alkaloids as bioactive 
constituents. Finally, it is concluded that neuropharmacological activities of 
A. acuminata are attributed due to these bioactive constituents. 
Table 3: Antidepressant activity of various fractions of ME of A. acuminata 
roots using FST.
Treatment Dose (mg/kg) Immobility time (sec)
Control Vehicle 158.17 ± 8.37a
Imipramine 5 42.33 ± 2.16*
EAF 100 43.33 ± 3.83*
BF 25 150.33 ± 6.05a
RME 70 153.83 ± 6.49a
n = 6; The data is expressed as Mean ± S.D.; *P<0.05 vs Control; aP<0.05 vs Imipramine; 
one way ANOVA followed by Student-Newman-Keul’s test.
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